NT5C3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.505200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.312800E-01
Normal-vs-Stage2
4.428200E-01
Normal-vs-Stage3
9.291600E-01
Normal-vs-Stage4
5.619600E-01
Stage1-vs-Stage2
9.542000E-01
Stage1-vs-Stage3
3.298200E-01
Stage1-vs-Stage4
9.286600E-01
Stage2-vs-Stage3
3.301800E-01
Stage2-vs-Stage4
8.881400E-01
Stage3-vs-Stage4
4.627400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.732000E-01
Normal-vs-AfricanAmerican
2.119000E-01
Normal-vs-Asian
2.508200E-01
Caucasian-vs-AfricanAmerican
9.114600E-01
Caucasian-vs-Asian
4.525000E-01
AfricanAmerican-vs-Asian
4.003000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.291600E-01
Normal-vs-Female
4.753200E-01
Male-vs-Female
2.667400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.832600E-01
Normal-vs-Age(41-60Yrs)
3.998800E-01
Normal-vs-Age(61-80Yrs)
4.896200E-01
Normal-vs-Age(81-100Yrs)
3.215000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.695200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.862400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.275200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.580200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.500800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.550400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.382800E-01
Normal-vs-Daily Drinker
4.539800E-01
Normal-vs-Weekly Drinker
9.531800E-01
Normal-vs-Occasional Drinker
3.269400E-01
Normal-vs-Social Drinker
5.275200E-01
Non Drinker-vs-Daily Drinker
1.628960E-01
Non Drinker-vs-Weekly Drinker
5.525400E-01
Non Drinker-vs-Occasional Drinker
8.482000E-02
Non Drinker-vs-Social Drinker
4.634400E-01
Daily Drinker-vs-Weekly Drinker
1.666410E-01
Daily Drinker-vs-Occasional Drinker
8.227400E-01
Daily Drinker-vs-Social Drinker
4.753400E-01
Weekly Drinker-vs-Occasional Drinker
8.528400E-02
Weekly Drinker-vs-Social Drinker
3.637600E-01
Occasional Drinker-vs-Social Drinker
3.059400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.695030E-01
Normal-vs-Grade 2
1.233860E-02
Normal-vs-Grade 3
6.924300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.444800E-01
Grade 1-vs-Grade 3
6.415000E-01
Grade 1-vs-Grade 4
1.695030E-01
Grade 2-vs-Grade 3
2.619000E-01
Grade 2-vs-Grade 4
1.233860E-02
Grade 3-vs-Grade 4
6.924300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.596200E-01
Normal-vs-NonDiabetic
4.534600E-01
Diabetic-vs-NonDiabetic
2.451800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.298600E-01
Normal-vs-NoPancreatitis
4.933200E-01
Pancreatitis-vs-NoPancreatitis
1.042050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.513800E-01
Normal-vs-N1
5.003600E-01
N0-vs-N1
7.224800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.159160E-01
Normal-vs-TP53-NonMutant
3.525200E-01
TP53-Mutant-vs-TP53-NonMutant
5.779800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
